Immtech International Inc., Pharm-Eco Laboratories Inc. deal

The companies formed a joint venture to manufacture and commercialize compounds developed by a research consortium led by the University of North Carolina, Chapel Hill (See BioCentury, March 24). Immtech gains transfer rights to commercialize the compounds from Pharm-Eco, which originally licensed them from the consortium. Immtech will manage clinical trials and be responsible for commercialization, while Pharm-Eco will manufacture the compounds, two of which will enter clinical trials this year. ...